These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10822236)

  • 1. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
    McKeith IG; Grace JB; Walker Z; Byrne EJ; Wilkinson D; Stevens T; Perry EK
    Int J Geriatr Psychiatry; 2000 May; 15(5):387-92. PubMed ID: 10822236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors for dementia with Lewy bodies.
    Wild R; Pettit T; Burns A
    Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
    Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
    Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
    McKeith I; Del Ser T; Spano P; Emre M; Wesnes K; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
    Lancet; 2000 Dec; 356(9247):2031-6. PubMed ID: 11145488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
    Maclean LE; Collins CC; Byrne EJ
    Int Psychogeriatr; 2001 Sep; 13(3):277-88. PubMed ID: 11768375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with lewy bodies: findings from an international multicentre study.
    Del Ser T; McKeith I; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
    Int J Geriatr Psychiatry; 2000 Nov; 15(11):1034-45. PubMed ID: 11113984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Scheepmaker AJ; Horstink MW; Hoefnagels WH; Strijks FE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):32-5. PubMed ID: 12564296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    Am J Alzheimers Dis Other Demen; 2007; 22(1):42-7. PubMed ID: 17534001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
    Cummings JL; Koumaras B; Chen M; Mirski D;
    Am J Geriatr Pharmacother; 2005 Sep; 3(3):137-48. PubMed ID: 16257816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Moerkens RM; Dhondt AD
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.
    Grace JB; Walker MP; McKeith IG
    Int J Geriatr Psychiatry; 2000 Nov; 15(11):1028-33. PubMed ID: 11113983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Mol JA
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
    Finkel SI
    Clin Ther; 2004 Jul; 26(7):980-90. PubMed ID: 15336465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
    Bhasin M; Rowan E; Edwards K; McKeith I
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):890-5. PubMed ID: 17265415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
    Bullock R; Cameron A
    Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
    Robert P
    Curr Med Res Opin; 2002; 18(3):156-71. PubMed ID: 12094826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with lewy bodies: therapeutic opportunities and pitfalls.
    Henriksen AL; St Dennis C; Setter SM; Tran JT
    Consult Pharm; 2006 Jul; 21(7):563-75. PubMed ID: 16934009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief review: rivastigmine, a second cholinesterase inhibitor.
    Patterson C; Hogan DB
    Can J Neurol Sci; 2001 Feb; 28 Suppl 1():S122-3. PubMed ID: 11237306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.